S
Soumya Swaminathan
Researcher at Indian Council of Medical Research
Publications - 370
Citations - 78067
Soumya Swaminathan is an academic researcher from Indian Council of Medical Research. The author has contributed to research in topics: Tuberculosis & Population. The author has an hindex of 69, co-authored 353 publications receiving 61963 citations. Previous affiliations of Soumya Swaminathan include Yahoo! & Ministry of Health and Family Welfare.
Papers
More filters
Journal Article
Preventive therapy for tuberculosis in HIV infected individuals.
TL;DR: Until the vast majority of HIV positive individuals in the world can access antiretroviral therapy, preventive therapy for tuberculosis should be offered at voluntary counselling and testing centres, as part of a package of care that includes prophylaxis and treatment of opportunistic infections, nutritional support and counselling.
Journal ArticleDOI
Short communication: association of HLA-A*1101 with resistance and B*4006 with susceptibility to HIV and HIV-TB: an in silico analysis of promiscuous T cell epitopes.
TL;DR: HLA-A*1101 may be associated with protection against HIV and the development of TB in HIV patients while HLA-B*4006 may beassociated with susceptibility to HIV and TB development in HIV Patients.
Journal Article
Incomplete immunological recovery following anti-tuberculosis treatment in HIV-infected individuals with active tuberculosis.
Luke Elizabeth Hanna,Kaustuv Nayak,Sudha Subramanyam,Perumal Venkatesan,P. R. Narayanan,Soumya Swaminathan +5 more
TL;DR: The findings of the study suggest that both HIV and TB act synergistically to activate the host immune system, indicating that underlying immune activation persists despite TB treatment.
Journal ArticleDOI
Bedaquiline, Delamanid, Linezolid, and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis
Vikram Vohra,Rathinam Sridhar,Lalit Kumar Anande,M. Muthuvijaylakshmi,Meera Bhatia Rana,S. Balaji,Prashant Shah,N. Saravanan,Vijay R. Chavan,Hemanth Kumar,Chinnayin Ponnuraja,V. Livchits,Monica Bahl,K.S. Sachdeva,Chandrasekaran Padmapriyadarsini,B Jeyadeepa,Lakshana,N. Akbar,Edwin Arulraj,R Karthikeyan,Muthukumar,Tamizharasan,S. Shivakumar,M. Muthuvijayalakshmi,Gayathri,C Ponnuraja,Ramesh,Neeta Singla,Vithal Prasad Myneedu,Ananiya Lawrence,Dipti Kushwaha,Deepak Kheraliya Shivam,R. Sarin,Anuj Bhatnagar,Gaurav Taneja,Alok Rawat,Mohd Harun Haniff,Rahul,Padma Rai,Savita Saini,Krishan Kumar Mathur,Rajesh Solanki,P. K. Patel,Vaidehi Prajapati,Bhavesh Parmar,Kajal Wadkar,Prashant K Shah,Snehal D. Parmar,palak Vyas,Krupa Mistri,Lalitkumar Anade,Vijaya Sayaji Chavan,Namrata Kaur Bhui,P Tipre,Daksha Shah,Surendra K Patwa,Anis Nhavakar,Audrey Brito,K. Keny,Kuntal Pal,Komal Godam,Madri Huje,Sanjana Ghadge,Madhuri Udmalle,Vivek Vijay Posture,Jaipal Bansode,Monica Bhal,Ranjan,Divya P Pillai,Supriya Semwal,Shirali Labroo Viktoriya Livchits,Reuben Swamikan,Dorothy Nanzala Nasubo,Mallik Parmar,Suvanad Sahu,Ya Diul Mukadi,Soumya Swaminathan +76 more
TL;DR: This regimen resulted in a satisfactory favorable outcome in pulmonary MDR-TB patients with additional drug resistance, and Cardiotoxicity was minimal, and myelosuppression, while common, was detected early and treated successfully.